2016

This policy brief provides antiretroviral therapy programme managers, implementing partners, procurement and supply chain managers, and other relevant stakeholders with key points to consider before and during the introduction of the new dosage form of ritonavir-boosted lopinavir (LPV/r) oral pellets.

In response to a longstanding demand for a heat-stable and easy to administer formulation of ritonavir boosted lopinavir (LPV/r) for infants and young children, a new formulation in pellet form is now available.

This fact sheet provides simplified information to facilitate proper dosing and administration of lopinavir and ritonavir 40mg/10mg oral pellets.

This document updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

This report presents the final results of the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. It summarizes country progress from 2009 to 2015. Entitled “On the Fast-track to an AIDS-Free Generation”, the report also highlights programmatic interventions undertaken at the country, regional and global levels. The end of the Global Plan heralds the new effort to stop pediatric AIDS, Start Free Stay Free AIDS Free, which was launched in 2016.

Caring for people living with HIV during the ebola outbreak in Sierra Leone. The outbreak of Ebola Virus Disease (EVD) that hit Sierra Leone in May 2014 ravaged communities, severely disrupting general health services and reducing access to those services. The epidemic rapidly spread to all districts in the country, with varying levels of intensity.